SCHEMBL1317043

SCHEMBL1317043

CC(=O)Oc1ccc(C(=O)Nc2cc(-c3ccccc3)ccc2C(=O)OC(C)(C)C)c(OCc2ccccc2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 3/20 0.43
▸ NR1H3 Q13133 3/20 0.43
▸ RXRA P19793 2/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ KDM4E B2RXH2 3/20 0.42
▸ PKM P14618 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ HDAC1 Q13547 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ MET P08581 1/20 0.41
▸ SGMS2 Q8NHU3 1/20 0.40
▸ MCL1 Q07820 1/20 0.40
▸ TDP1 Q9NUW8 2/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ LRRK2 Q5S007 1/20 0.39
▸ MAPT P10636 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1316511 0.95 LRRK2 (0.44) NR1H2NR1H3RXRAALDH1A1KDM4E
SCHEMBL1316898 0.92 MCL1 (0.47) NR1H2NR1H3RXRAALDH1A1KDM4E
SCHEMBL1317655 0.89 GAA (0.46) NR1H2NR1H3RXRAMEN1KMT2A
SCHEMBL1317041 0.88 HDAC1 (0.43) NR1H2NR1H3RXRAALDH1A1KDM4E
SCHEMBL1317087 0.88 MET (0.45) NR1H2NR1H3RXRAHDAC1MET
SCHEMBL1315346 0.87 HDAC1 (0.42) NR1H2NR1H3RXRAALDH1A1KDM4E
SCHEMBL1316825 0.86 LRRK2 (0.52) NR1H2NR1H3RXRAMEN1KMT2A
SCHEMBL1316899 0.86 GAA (0.43) NR1H2NR1H3RXRAALDH1A1PKM
SCHEMBL1316105 0.85 LRRK2 (0.45) NR1H2NR1H3RXRAALDH1A1KDM4E
SCHEMBL1316297 0.85 LRRK2 (0.48) ALDH1A1KDM4EPKMMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492582-B2 N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2013-07-23 — — US disclosed
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2011-11-10 — — US disclosed
EP-2385036-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF Toyama Chemical Co., Ltd. (JP) 2011-11-09 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF COL14A1, COL2A1, COL1A1 NR1H2 1004/4885NR1H3 835/4885RXRA 647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback